DCs also expressed GLP-1R (Figures 5a and d)
If you do find yourself with persistent gastritis, then it is best to see a doctor and find out about the underlying cause
Non-alcoholic fatty liver disease affects approximately 30% of the general population and is substantially more prevalent among individuals with obesity
In clinical trials of SGLT2 inhibitors in type 2 diabetes, discontinuation rates among those receiving active treatment have been less variable, ranging from 21% during a median follow-up time of 50 months in the DECLARE-TIMI 58 trial of dapagliflozin to 29% during a mean follow-up time of 43 months in the CANVAS trial of canagliflozin [14,15,16,17,18]
Understanding insurance coverage for weight loss medications can be challenging, but its always worth rechecking your benefitsespecially if your coverage has changed due to a job switch, adding or removing dependents, or transitioning to a spouses plan
TH: Conceptualization, Funding acquisition, Supervision, Writing review & editing